|
Aug 8
|
Pharmacosmos ventures into oncology and merges with G1 Therapeutics
|
|
Aug 8
|
G1 Therapeutics (GTHX) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 8
|
G1 Therapeutics Provides Second Quarter 2024 Financial Results and Operational Highlights
|
|
Aug 7
|
Top Midday Gainers
|
|
Aug 7
|
Pharmacosmos Group to Acquire G1 Therapeutics
|
|
Jul 26
|
G1 Therapeutics, Inc.'s (NASDAQ:GTHX) top owners are retail investors with 56% stake, while 28% is held by institutions
|
|
Jul 25
|
G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
|
|
Jun 25
|
G1 Therapeutics discontinue COSELA in TNBC following Phase III flop
|
|
Jun 24
|
G1 Therapeutics Provides Update on Phase 3 PRESERVE 2 Trial in Patients Receiving Trilaciclib Prior to First Line Chemotherapy in Metastatic Triple Negative Breast Cancer (mTNBC)
|
|
May 28
|
Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC)
|
|
May 23
|
G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting
|
|
May 22
|
G1 Therapeutics to Participate in TD Cowen’s 5th Annual Oncology Innovation Summit
|
|
May 22
|
G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses
|
|
May 4
|
G1 Therapeutics, Inc. (NASDAQ:GTHX) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
|
|
May 3
|
G1 Therapeutics First Quarter 2024 Earnings: Revenues Disappoint
|
|
May 2
|
G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript
|
|
May 2
|
G1 Therapeutics Inc (GTHX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...
|
|
May 2
|
Q1 2024 G1 Therapeutics Inc Earnings Call
|
|
May 1
|
G1 Therapeutics Inc (GTHX) Q1 2024 Earnings: Close Alignment with Analyst Revenue Projections
|
|
May 1
|
G1 Therapeutics (GTHX) Reports Q1 Loss, Lags Revenue Estimates
|